BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 24886063)

  • 1. Mining the pre-diagnostic antibody repertoire of TgMMTV-neu mice to identify autoantibodies useful for the early detection of human breast cancer.
    Mao J; Ladd J; Gad E; Rastetter L; Johnson MM; Marzbani E; Childs JS; Lu H; Dang Y; Broussard E; Stanton SE; Hanash SM; Disis ML
    J Transl Med; 2014 May; 12():121. PubMed ID: 24886063
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumor-associated antigens identified early in mouse mammary tumor development can be effective vaccine targets.
    Stanton SE; Gad E; Corulli LR; Lu H; Disis ML
    Vaccine; 2019 Jun; 37(27):3552-3561. PubMed ID: 31126858
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Tumor-associated autoantibodies in ESCC screening: Detecting prevalent early-stage malignancy or predicting future cancer risk?
    Wang M; Liu F; Pan Y; Xu R; Li F; Liu A; Yang H; Duan L; Shen L; Wu Q; Liu Y; Liu M; Liu Z; Hu Z; Chen H; Cai H; He Z; Ke Y
    EBioMedicine; 2021 Nov; 73():103674. PubMed ID: 34753106
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The Combination of IgA and IgG autoantibodies against Transcriptional Intermediary Factor-1γ contributes to the early diagnosis of Lung Cancer.
    Yu L; Lin X; Zhang L; Wu Q; Zhang S; Chen D; Pan X; Huang Y
    Int J Med Sci; 2020; 17(11):1561-1568. PubMed ID: 32669959
    [No Abstract]   [Full Text] [Related]  

  • 5. Tumor-associated autoantibodies from mouse breast cancer models are found in serum of breast cancer patients.
    Stanton SE; Gad E; Ramos E; Corulli L; Annis J; Childs J; Katayama H; Hanash S; Marks J; Disis ML
    NPJ Breast Cancer; 2021 May; 7(1):50. PubMed ID: 33976232
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Evaluation of known oncoantibodies, HER2, p53, and cyclin B1, in prediagnostic breast cancer sera.
    Lu H; Ladd J; Feng Z; Wu M; Goodell V; Pitteri SJ; Li CI; Prentice R; Hanash SM; Disis ML
    Cancer Prev Res (Phila); 2012 Aug; 5(8):1036-43. PubMed ID: 22715141
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Autoantibodies against tumor-associated antigens in the early detection of lung cancer.
    Dai L; Tsay JC; Li J; Yie TA; Munger JS; Pass H; Rom WN; Zhang Y; Tan EM; Zhang JY
    Lung Cancer; 2016 Sep; 99():172-9. PubMed ID: 27565936
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Autoantibodies to aberrantly glycosylated MUC1 in early stage breast cancer are associated with a better prognosis.
    Blixt O; Bueti D; Burford B; Allen D; Julien S; Hollingsworth M; Gammerman A; Fentiman I; Taylor-Papadimitriou J; Burchell JM
    Breast Cancer Res; 2011 Mar; 13(2):R25. PubMed ID: 21385452
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Autoantibodies as potential biomarkers for breast cancer.
    Zhong L; Ge K; Zu JC; Zhao LH; Shen WK; Wang JF; Zhang XG; Gao X; Hu W; Yen Y; Kernstine KH
    Breast Cancer Res; 2008; 10(3):R40. PubMed ID: 18460216
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Identification and validation of new autoantibodies for the diagnosis of DCIS and node negative early-stage breast cancers.
    Lacombe J; Mangé A; Jarlier M; Bascoul-Mollevi C; Rouanet P; Lamy PJ; Maudelonde T; Solassol J
    Int J Cancer; 2013 Mar; 132(5):1105-13. PubMed ID: 22886747
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tumor-associated autoantibody signature for the early detection of gastric cancer.
    Zayakin P; Ancāns G; Siliņa K; Meistere I; Kalniņa Z; Andrejeva D; Endzeliņš E; Ivanova L; Pismennaja A; Ruskule A; Doniņa S; Wex T; Malfertheiner P; Leja M; Linē A
    Int J Cancer; 2013 Jan; 132(1):137-47. PubMed ID: 22684876
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Classifying patients for breast cancer by detection of autoantibodies against a panel of conformation-carrying antigens.
    Evans RL; Pottala JV; Egland KA
    Cancer Prev Res (Phila); 2014 May; 7(5):545-55. PubMed ID: 24641868
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Therapeutic and Prophylactic Antitumor Activity of an Oral Inhibitor of Fucosylation in Spontaneous Mammary Cancers.
    Disis ML; Corulli LR; Gad EA; Koehnlein MR; Cecil DL; Senter PD; Gardai SJ; Okeley NM
    Mol Cancer Ther; 2020 May; 19(5):1102-1109. PubMed ID: 32165557
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Identification of a new panel of serum autoantibodies associated with the presence of in situ carcinoma of the breast in younger women.
    Desmetz C; Bascoul-Mollevi C; Rochaix P; Lamy PJ; Kramar A; Rouanet P; Maudelonde T; Mangé A; Solassol J
    Clin Cancer Res; 2009 Jul; 15(14):4733-41. PubMed ID: 19584157
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Discovery and Validation of Serum Autoantibodies Against Tumor-Associated Antigens as Biomarkers in Gastric Adenocarcinoma Based on the Focused Protein Arrays.
    Yang Q; Qin J; Sun G; Qiu C; Jiang D; Ye H; Wang X; Dai L; Zhu J; Wang P; Zhang J
    Clin Transl Gastroenterol; 2020 Dec; 12(1):e00284. PubMed ID: 33346593
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The tumor antigen repertoire identified in tumor-bearing neu transgenic mice predicts human tumor antigens.
    Lu H; Knutson KL; Gad E; Disis ML
    Cancer Res; 2006 Oct; 66(19):9754-61. PubMed ID: 17018635
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Autoantibodies to Ezrin are an early sign of pancreatic cancer in humans and in genetically engineered mouse models.
    Capello M; Cappello P; Linty FC; Chiarle R; Sperduti I; Novarino A; Salacone P; Mandili G; Naccarati A; Sacerdote C; Beghelli S; Bersani S; Barbi S; Bassi C; Scarpa A; Nisticò P; Giovarelli M; Vineis P; Milella M; Novelli F
    J Hematol Oncol; 2013 Sep; 6():67. PubMed ID: 24010981
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Autoantibodies in breast cancer sera: candidate biomarkers and reporters of tumorigenesis.
    Fernández Madrid F
    Cancer Lett; 2005 Dec; 230(2):187-98. PubMed ID: 16297705
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Combined detection of serum autoantibodies as diagnostic biomarkers in esophagogastric junction adenocarcinoma.
    Xu YW; Chen H; Guo HP; Yang SH; Luo YH; Liu CT; Huang XY; Tang XM; Hong CQ; Li EM; Xu LY; Peng YH
    Gastric Cancer; 2019 May; 22(3):546-557. PubMed ID: 30426295
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Usefulness of Salivary and Serum Auto-antibodies Against Tumor Biomarkers HER2 and MUC1 in Breast Cancer Screening.
    Laidi F; Bouziane A; Errachid A; Zaoui F
    Asian Pac J Cancer Prev; 2016; 17(1):335-9. PubMed ID: 26838233
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.